Endoscopic Hemostatic and Sedative Treatment of Esophageal and Gastric Variceal Bleeding
Status:
Recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
Remazolam besylate was used for sedation during endoscopic hemostasis in patients with
esophageal and gastric varices rupture and bleeding in liver cirrhosis. The onset time,
recovery time and incidence of adverse reactions were observed.